These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 33161098)

  • 21. COVID-19 and cardiovascular diseases.
    Liu F; Liu F; Wang L
    J Mol Cell Biol; 2021 Jul; 13(3):161-167. PubMed ID: 33226078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Research Status of SARS-CoV-2 on Cardiovascular System Injury in Children.
    Zhang Y; Wang L; Wei S
    Braz J Cardiovasc Surg; 2021 Oct; 36(5):685-690. PubMed ID: 33355798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The evolution of cardiovascular COVID-19 research.
    Kotecha T; Knight DS; Moon JC; Cole GD; Fontana M
    Eur Heart J; 2021 Aug; 42(30):2953-2954. PubMed ID: 34166510
    [No Abstract]   [Full Text] [Related]  

  • 24. To Be or Not to Be a Multimodality Imager!
    Chandrashekhar Y; Narula J
    JACC Cardiovasc Imaging; 2017 Jun; 10(6):715-717. PubMed ID: 28595845
    [No Abstract]   [Full Text] [Related]  

  • 25. [Nuclear Cardiology in the COVID-19 pandemic].
    Milà López M; Jiménez Heffernan A; Sánchez de Mora E; Fierro Alanis MP
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2023; 42(2):106-112. PubMed ID: 36683949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multimodality imaging approach in diagnosis and therapy of various cardiovascular conditions.
    Belyavskiy E
    J Clin Ultrasound; 2022 Oct; 50(8):1025. PubMed ID: 36218200
    [No Abstract]   [Full Text] [Related]  

  • 27. Cardiovascular Tropism and Sequelae of SARS-CoV-2 Infection.
    Dmytrenko O; Lavine KJ
    Viruses; 2022 May; 14(6):. PubMed ID: 35746609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Potential mechanisms and management strategies of COVID-19 induced effects on cardiovascular system].
    Feng YF; Dong CJ; Ma AQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Dec; 49(12):1261-1266. PubMed ID: 34905909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urgent Need for Studies of the Late Effects of SARS-CoV-2 on the Cardiovascular System.
    Maleszewski JJ; Young PM; Ackerman MJ; Halushka MK
    Circulation; 2021 Mar; 143(13):1271-1273. PubMed ID: 32969710
    [No Abstract]   [Full Text] [Related]  

  • 30. Management of acute cardiovascular events in patients with COVID-19.
    Liao CT; Chang WT; Yu WL; Toh HS
    Rev Cardiovasc Med; 2020 Dec; 21(4):577-581. PubMed ID: 33388002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of SARS-CoV-2 treatment on the cardiovascular system: an updated review.
    Akkaif MA; Sha'aban A; Cesaro A; Jaber AAS; Vergara A; Yunusa I; Jatau AI; Mohammed M; Govindasamy GS; Al-Mansoub MA; Sheikh Abdul Kader MA; Ibrahim B
    Inflammopharmacology; 2022 Aug; 30(4):1143-1151. PubMed ID: 35701719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular Care of the Oncology Patient During COVID-19: An Expert Consensus Document From the ACC Cardio-Oncology and Imaging Councils.
    Baldassarre LA; Yang EH; Cheng RK; DeCara JM; Dent S; Liu JE; Rudski LG; Strom JB; Thavendiranathan P; Barac A; Zaha VG; Bucciarelli-Ducci C; Ellahham S; Deswal A; Lenneman C; Villarraga HR; Blaes AH; Ismail-Khan R; Ky B; Leja MJ; Scherrer-Crosbie M
    J Natl Cancer Inst; 2021 May; 113(5):513-522. PubMed ID: 33179744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Consequences of COVID-19 on the cardiovascular and renal systems.
    Zhu Y; Zhang X; Peng Z
    Sleep Med; 2022 Dec; 100():31-38. PubMed ID: 35994936
    [No Abstract]   [Full Text] [Related]  

  • 34. The cardiovascular legacy of the COVID-19 pandemic.
    Bhatt AS; Vaduganathan M
    Eur Heart J; 2022 Sep; 43(33):3179-3181. PubMed ID: 35680618
    [No Abstract]   [Full Text] [Related]  

  • 35. A novel COVID-19 and its effects on cardiovascular disease.
    Paramasivam A; Priyadharsini JV; Raghunandhakumar S; Elumalai P
    Hypertens Res; 2020 Jul; 43(7):729-730. PubMed ID: 32355222
    [No Abstract]   [Full Text] [Related]  

  • 36. COVID and Cardiovascular Disease: What We Know in 2021.
    Chilazi M; Duffy EY; Thakkar A; Michos ED
    Curr Atheroscler Rep; 2021 May; 23(7):37. PubMed ID: 33983522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of cardiovascular system as the critical point in coronavirus disease 2019 (COVID-19) prognosis and recovery.
    Lazaridis C; Vlachogiannis NI; Bakogiannis C; Spyridopoulos I; Stamatelopoulos K; Kanakakis I; Vassilikos V; Stellos K
    Hellenic J Cardiol; 2020; 61(6):381-395. PubMed ID: 32534109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In Reply - COVID-19, the Female Immune Advantage, and Cardiovascular Impact.
    Ritter O; Kararigas G
    Mayo Clin Proc; 2021 Mar; 96(3):821-822. PubMed ID: 33673934
    [No Abstract]   [Full Text] [Related]  

  • 39. COVID-19, the Female Immune Advantage, and Cardiovascular Impact.
    Gersh FL; O'Keefe JH; Henry BM
    Mayo Clin Proc; 2021 Mar; 96(3):820-821. PubMed ID: 33673933
    [No Abstract]   [Full Text] [Related]  

  • 40. COVID-19 and the cardiovascular system: an update.
    Salabei JK; Asnake ZT; Ismail ZH; Charles K; Stanger GT; Abdullahi AH; Abraham AT; Okonoboh P
    Am J Med Sci; 2022 Aug; 364(2):139-147. PubMed ID: 35151635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.